Half-year report · Q2
2413.TEDINET S100UO9S
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥124.8bn | 2024-04-01 → 2024-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥238.9bn | 2023-04-01 → 2024-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥115.8bn | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Operating income | ¥29.0bn | 2024-04-01 → 2024-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥34.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥29.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥68.8bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥37.3bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥17.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥45.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥23.4bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥19.6bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥25.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Total assets | ¥491.5bn | at 2024-09-30 | Cons. | Assets IFRS |
| Total assets | ¥490.8bn | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥461.0bn | at 2023-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥127.0bn | at 2024-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥124.1bn | at 2024-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥364.4bn | at 2024-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥366.7bn | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥345.2bn | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥309.5bn | at 2023-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥349.5bn | at 2024-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥351.9bn | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥331.6bn | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥148.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥149.7bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥135.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥118.3bn | at 2023-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥23.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥58.3bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥26.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥11.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥39.5bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥28.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥12.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥9.4bn | 2023-04-01 → 2024-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥15.3bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥25.47 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥66.68 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥34.47 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥25.4 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥66.63 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥34.45 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 71.1% | at 2024-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.9% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥1.9bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.7bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.6bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥18m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥11.9bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥100m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥42.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥40.7bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥38.0bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥38.0bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥28m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥6.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥21.6bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥125.6bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥123.7bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥30.3bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥1.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | ¥125m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥9.0bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥9.0bn |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥21m |
| jpcrp040300-q2r_E05425-000Career Solutionreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥13.8bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥13.6bn |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥215m |
| jpcrp040300-q2r_E05425-000Evidence Solutionreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥3.6bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥45.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥44.0bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E05425-000Medical Platformreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥18.4bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥32.7bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥32.6bn |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11m |
| jpcrp040300-q2r_E05425-000Overseasreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥7.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7m |
| jpcrp040300-q2r_E05425-000Site Solutionreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.8bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥116.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥114.6bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥34.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 642
| Item | Context | Value | Unit |
|---|---|---|---|
| Payments for loans receivable inv cf IFRS | CurrentYTDDuration | -1000000 | JPY |
| Collection of loans receivable inv cf IFRS | Prior1YTDDuration | 7000000 | JPY |
| Collection of loans receivable inv cf IFRS | CurrentYTDDuration | 12000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | Prior1YTDDuration | -15279000000 | JPY |
| Payments for acquisition of subsidiaries inv cf IFRS | CurrentYTDDuration | -3238000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | Prior1YTDDuration | -4053000000 | JPY |
| Payments for acquisition of businesses inv cf IFRS | CurrentYTDDuration | -38000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | 116000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | 93000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -28321000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -11325000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | Prior1YTDDuration | -12893000000 | JPY |
| Dividends paid to owners of parent fin cf IFRS | CurrentYTDDuration | -14252000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | Prior1YTDDuration | -2464000000 | JPY |
| Dividends paid to non controlling interests fin cf IFRS | CurrentYTDDuration | -1904000000 | JPY |
| Capital contribution from non controlling interests fin cf IFRS | Prior1YTDDuration | 13109000000 | JPY |
| Capital contribution from non controlling interests fin cf IFRS | CurrentYTDDuration | － | JPY |
| Proceeds from long term borrowings fin cf IFRS | Prior1YTDDuration | 19926000000 | JPY |
| Proceeds from long term borrowings fin cf IFRS | CurrentYTDDuration | 6960000000 | JPY |
| Repayments of borrowings fin cf IFRS | Prior1YTDDuration | -533000000 | JPY |
| Repayments of borrowings fin cf IFRS | CurrentYTDDuration | -1407000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | Prior1YTDDuration | 50000000 | JPY |
| Proceeds from issuance of shares fin cf IFRS | CurrentYTDDuration | 0 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -1879000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -2141000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | 4000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | 103000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | 15320000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -12639000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 2914000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | -1180000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | 16734000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | -1549000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 118319000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 149661000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 135053000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 148112000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000MedicalPlatformReportableSegmentMember | 44013000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000EvidenceSolutionReportableSegmentMember | 13628000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000CareerSolutionReportableSegmentMember | 9012000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000SiteSolutionReportableSegmentMember | 15339000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000OverseasReportableSegmentMember | 32644000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 114636000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000OtherEmergingBusinessMember | 1159000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration | 115795000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000MedicalPlatformReportableSegmentMember | 1490000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000EvidenceSolutionReportableSegmentMember | 215000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000CareerSolutionReportableSegmentMember | 21000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E05425-000SiteSolutionReportableSegmentMember | 7000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |